VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.6200
-0.0072 (-1.15%)
At close: Aug 13, 2025, 4:00 PM
0.6200
0.00 (0.00%)
After-hours: Aug 13, 2025, 6:30 PM EDT
VolitionRx Employees
VolitionRx had 85 employees as of December 31, 2024. The number of employees decreased by 25 or -22.73% compared to the previous year.
Employees
85
Change (1Y)
-25
Growth (1Y)
-22.73%
Revenue / Employee
$15,392
Profits / Employee
-$282,638
Market Cap
63.87M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
VNRX News
- 5 days ago - VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update - PRNewsWire
- 9 days ago - VolitionRx Announces Pricing of $1.2 Million Registered Direct Offering - PRNewsWire
- 4 weeks ago - Nu.Q® Discover Expands Global Adoption and Epigenetic Innovation - PRNewsWire
- 5 weeks ago - Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes - PRNewsWire
- 2 months ago - Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure - PRNewsWire
- 2 months ago - Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties - PRNewsWire
- 3 months ago - VolitionRx Limited Announces Successful Detection of Nucleosomes in Cats - PRNewsWire
- 3 months ago - VolitionRX Limited (VNRX) Q1 2025 Earnings Call Transcript - Seeking Alpha